BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9049328)

  • 1. Detection of silencer activity in the long control regions of human papillomavirus type 6 isolated from both benign and malignant lesions.
    Farr A; Pattison S; Youn BS; Roman A
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():827-35. PubMed ID: 9049328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative enhancer activity and transforming potential of authentic human papillomavirus type 6 genomes from benign and malignant lesions.
    Farr A; Wang H; Kasher MS; Roman A
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():519-26. PubMed ID: 1848589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchanges in the E6 and E7 proteins.
    Grassmann K; Wilczynski SP; Cook N; Rapp B; Iftner T
    Virology; 1996 Sep; 223(1):185-97. PubMed ID: 8806552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.
    Tornesello ML; Buonaguro FM; Buonaguro L; Salatiello I; Beth-Giraldo E; Giraldo G
    J Gen Virol; 2000 Dec; 81(Pt 12):2969-2982. PubMed ID: 11086128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
    Kook JK; Kim JH; Min BM
    Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
    Yasumoto S; Taniguchi A; Sohma K
    J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences.
    Chen Z; Storthz KA; Shillitoe EJ
    Cancer Res; 1997 Apr; 57(8):1614-9. PubMed ID: 9108468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients.
    Tornesello ML; Buonaguro FM; Meglio A; Buonaguro L; Beth-Giraldo E; Giraldo G
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2199-208. PubMed ID: 9292007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [No switch region is found in the regulatory sequence of HPV 16 for promoter P97].
    Dong X; Liu H; Pfister H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):325-7. PubMed ID: 12759968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes.
    Thomas JT; Oh ST; Terhune SS; Laimins LA
    J Virol; 2001 Aug; 75(16):7564-71. PubMed ID: 11462028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-2 isolates from patients with huge verrucae vulgaris possess stronger promoter activities.
    Lei YJ; Wang C; Gao C; Jiang HY; Chen JM; Han J; Yuan YK; Dong XP
    Intervirology; 2007; 50(5):353-60. PubMed ID: 17728546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin.
    Kagie MJ; Kenter GG; Zomerdijk-Nooijen Y; Hermans J; Schuuring E; Timmers PJ; Trimbos JB; Fleuren GJ
    Gynecol Oncol; 1997 Nov; 67(2):178-83. PubMed ID: 9367704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18.
    Romanczuk H; Villa LL; Schlegel R; Howley PM
    J Virol; 1991 May; 65(5):2739-44. PubMed ID: 1850048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
    Mistry N; Simonsson M; Evander M
    Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region.
    Villa LL; Schlegel R
    Virology; 1991 Mar; 181(1):374-7. PubMed ID: 1847260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].
    Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V
    Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women.
    Aho J; Hankins C; Tremblay C; Lang F; Forest P; Pourreaux K; Rouah F; Coutlée F;
    J Infect Dis; 2003 Nov; 188(10):1517-27. PubMed ID: 14624377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.